Clinical trials
31 active studies led by ModernaTX, Inc., of 119 in all
Source: ClinicalTrials.gov, Studies with ModernaTX, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 8Markets in public records
- 0Regions & countries
- 31Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by ModernaTX, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on ModernaTX, Inc.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies ModernaTX, Inc. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with ModernaTX, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show ModernaTX, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets ModernaTX, Inc. is in.
From our blog
Stories on the topics ModernaTX, Inc. works in.
Immune Health Supplements After the Pandemic
Seasonal flu causes about a billion cases a year. Vitamin C and zinc can shorten colds a little, but vaccines…
Read
Molecular Point-of-Care Tests: Lab Accuracy, Clinic Speed
TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Read
Antimicrobial Resistance: Why Faster Testing Matters
Drug-resistant infections already kill over a million people a year. Faster testing helps doctors pick the…
Read